Company

Lyterian Therapeutics

Biotechnology Research South San Francisco, California, United States 33 employees

Employees: 33
Contacts: 4
Emails: 4
Phones: 3

lyterian.com LinkedIn

Lyterian Therapeutics Overview

Headquarters: South San Francisco, California, United States
Website: lyterian.com
Industry: Biotechnology Research
Employees: 33
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology and Pharmaceuticals

About Lyterian Therapeutics

Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.

Lyterian Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Lyterian Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Fabio Pucci	Biotech Investor at Leaps by Bayer	Boston, Massachusetts, United States	Email
Fan Gao	Wherever You Are, Whatever You Do, Pick	Burlingame, California, United States	Email Phone
Ray Deshaies, Ph.d.		Los Angeles Metropolitan Area, United States	Email Phone
Zhonghua Pei	Senior Vice President of Chemistry	South San Francisco, California, United States	Email Phone